Amanote Research
Register
Sign In
In Silico Evaluation of Benzo (F) Chromen-3-One as a Potential Inhibitor of NF-κB: A Key Regulatory Molecule in Inflammation-Mediated Pathogenesis of Diabetes, Alzheimer’s, and Cancer
Journal of Applied Pharmaceutical Science
- India
doi 10.7324/japs.2018.81218
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Toxicology
Pharmaceutics
Pharmacology
Date
December 1, 2018
Authors
Unknown
Publisher
Journal of Applied Pharmaceutical Science
Related search
Bridging the Gap: A Regulator of NF-κB Linking Inflammation and Cancer
Journal of Oral Biosciences
Biochemistry
Medicine
Genetics
Molecular Biology
Dentistry
NF-κB Signaling Pathway, Inflammation and Colorectal Cancer
Cellular and Molecular Immunology
Infectious Diseases
Medicine
Allergy
Immunology
NF-κB as Potential Target in the Treatment of Melanoma
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Expression and Polymorphism of Toll-Like Receptor 4 and Effect on NF-κB Mediated Inflammation in Colon Cancer Patients
PLoS ONE
Multidisciplinary
Chronic Inflammation in Biomaterial-Induced Periprosthetic Osteolysis: NF-κB as a Therapeutic Target
Acta Biomaterialia
Molecular Biology
Biochemistry
Biomaterials
Medicine
Biotechnology
Biomedical Engineering
Photophysical Properties of Novel Fluorescent 1-(3-Hydroxy-Benzofuran-2-Yl)-Benzo[f]chromen-3-One Derivative: Models for Correlation Solvent Polarity Scales
Canadian Journal of Physics
Astronomy
Physics
CP8-9 NF-κB Function Inhibitor, DHMEQ as a Treatment Option for Advanced Urological Cancer
Japanese Journal of Urology
Urology
Identification of REPS2 as a Putative Modulator of NF-κB Activity in Prostate Cancer Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
Involvement of NF-κB-mediated Expression of Galectin-3-Binding Protein in TNF-α-induced Breast Cancer Cell Adhesion
Oncology Reports
Medicine
Cancer Research
Oncology
